Lyra Therapeutics (LYRA) Change in Account Payables (2019 - 2025)
Quarterly Change in Account Payables rose 109.25% to $103000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$516000.0 through Dec 2025, up 72.66% year-over-year, with the annual reading at -$516000.0 for FY2025, 72.66% up from the prior year.
Lyra Therapeutics' Change in Account Payables history spans 7 years, with the latest figure at $103000.0 for Q4 2025.
- Change in Account Payables came in at $103000.0 for Q4 2025, up from -$120000.0 in the prior quarter.
- In the past five years, Change in Account Payables ranged from a high of $3.3 million in Q1 2023 to a low of -$3.5 million in Q4 2023.
- The 5-year median for Change in Account Payables is -$75500.0 (2023), against an average of -$100700.0.
- Year-over-year, Change in Account Payables surged 14033.33% in 2021 and then tumbled 435.4% in 2022.
- Lyra Therapeutics' Change in Account Payables stood at $1.2 million in 2021, then plummeted by 289.69% to -$2.2 million in 2022, then plummeted by 57.53% to -$3.5 million in 2023, then surged by 68.51% to -$1.1 million in 2024, then soared by 109.25% to $103000.0 in 2025.
- Per Business Quant, the three most recent readings for LYRA's Change in Account Payables are $103000.0 (Q4 2025), -$120000.0 (Q3 2025), and -$45000.0 (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | -3.26 Mn |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 35.60 Mn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | - |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | - |
| 10 | Lyra Therapeutics | - | - | - | 103,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 103,000.00 |
| Dec 31, 2025 | 103,000.00 |
| Sep 30, 2025 | -120,000.00 |
| Sep 30, 2025 | -120,000.00 |
| Jun 30, 2025 | -45,000.00 |
| Jun 30, 2025 | -45,000.00 |
| Mar 31, 2025 | -454,000.00 |
| Mar 31, 2025 | -454,000.00 |
| Dec 31, 2024 | -1.11 Mn |
| Dec 31, 2024 | -1.11 Mn |
| Sep 30, 2024 | -2.59 Mn |
| Sep 30, 2024 | -2.59 Mn |
| Jun 30, 2024 | 2.38 Mn |
| Jun 30, 2024 | 2.38 Mn |
| Mar 31, 2024 | -560,000.00 |
| Mar 31, 2024 | -560,000.00 |
| Dec 31, 2023 | -3.54 Mn |
| Dec 31, 2023 | -3.54 Mn |
| Sep 30, 2023 | 796,000.00 |
| Sep 30, 2023 | 796,000.00 |
| Jun 30, 2023 | -106,000.00 |
| Jun 30, 2023 | -106,000.00 |
| Mar 31, 2023 | 3.30 Mn |
| Mar 31, 2023 | 3.30 Mn |
| Dec 31, 2022 | -2.24 Mn |
| Dec 31, 2022 | -2.24 Mn |
| Sep 30, 2022 | 1.47 Mn |
| Sep 30, 2022 | 1.47 Mn |
| Jun 30, 2022 | -976,000.00 |
| Jun 30, 2022 | -976,000.00 |
| Mar 31, 2022 | -663,000.00 |
| Mar 31, 2022 | -663,000.00 |
| Dec 31, 2021 | 1.18 Mn |
| Dec 31, 2021 | 1.18 Mn |
| Sep 30, 2021 | 424,000.00 |
| Sep 30, 2021 | 424,000.00 |
| Jun 30, 2021 | 291,000.00 |
| Jun 30, 2021 | 291,000.00 |
| Mar 31, 2021 | 452,000.00 |
| Mar 31, 2021 | 452,000.00 |
| Dec 31, 2020 | 204,000.00 |
| Dec 31, 2020 | 204,000.00 |
| Sep 30, 2020 | 3,000.00 |
| Sep 30, 2020 | 3,000.00 |
| Jun 30, 2020 | -294,000.00 |
| Jun 30, 2020 | -294,000.00 |
| Mar 31, 2020 | 432,000.00 |
| Mar 31, 2020 | 432,000.00 |
| Dec 31, 2019 | -120,000.00 |
| Dec 31, 2019 | -120,000.00 |
| Sep 30, 2019 | -924,000.00 |
| Sep 30, 2019 | -924,000.00 |
| Jun 30, 2019 | 885,000.00 |
| Jun 30, 2019 | 885,000.00 |
| Mar 31, 2019 | -46,000.00 |
| Mar 31, 2019 | -46,000.00 |